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Abstract 
Modern fluorescent modalities play an important role in the functional diagnostic of various physiological processes in living 
tissues. Utilizing the fluorescence spectroscopy approach we observe the circulation of fluorescent-labelled nanocapsules 
with rhodamine tetramethylrhodamine in a microcirculatory blood system. The measurements were conducted 
transcutaneously on the surface of healthy Wistar rat thighs in vivo. The administration of the preparation capsule suspension 
with a rhodamine concentration of 5 mg kg−1 of the animal weight resulted in a two-fold increase of fluorescence intensity 
relative to the baseline level. The dissemination of nanocapsules in the adjacent tissues via the circulatory system was 
observed and assessed quantitatively. The approach can be used for the transdermal assessment of rhodamine-loaded 
capsules in vivo. 
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1. Introduction 
The conventional monitoring of administrated substance 
distribution in animals requires specimen preparation 
including the staining of the tissue to determine the 
localization and concentration of various analytes. Typically, 
invasive and destructive tests cannot be applied to record the 
dynamics of the distribution processes within a certain time. 
Therefore, methods for whole animal imaging in vivo have 
undergone rapid development [1]. Such approaches appear 
promising, making it possible to measure a single point of the 
sample or to perform the imaging of the entire animal body and 
reveal the related biological processes in real time. In major 
cases, minimally invasive intervention is required [2]. From 
this point of view, optical noninvasive diagnostic approaches 
are of particular interest because of their high sensitivity, 
versatility and low cost. To obtain reliable information in vivo, 
various optical methods have been developed and successfully 
used in various medical applications in the past [3, 4]. Optical 
coherence tomography has been effectively utilized to assess 
the efficiency of percutaneous vaccine delivery [5, 6]. 
Intravital microscopy has been used for the noninvasive 
continuous monitoring of blood flow [7, 8] and drug transfer 
in the body [9]. Photoacoustic imaging has been successfully 
applied to visualize transport and the accumulation of 
substances in organs or in tumour tissue [3]. Laser-induced 
fluorescence techniques can also be assigned to monitoring 
methods inside the body utilizing microencapsulated 
biomarkers [10, 11]. The optical diagnostic approach also has 
considerable potential in preclinical and clinical trials [12]. 
Another vibrant area is the targeted delivery of drugs, which 
is able to significantly improve the effectiveness of the 
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treatment of various diseases, and reduce the occurrence of 
possible adverse side effects and disease complications. The 
development of such controlled-release preparations, in many 
cases, is associated with the design of a microscopic nanoscale 
system, such as capsules for loading biologically active 
substances and delivering them directly to the target. Thus, the 
encapsulation of biologically active materials for drug delivery 
in vivo is a complex task requiring significant fundamental and 
applied research, including the development of nanocapsules 
for drug transportation as well as in vivo delivery control 
technology [13, 14]. One of the recent advancements in the 
field is the fabrication of porous inorganic nanoparticles with 
high chemical and mechanical stability, as well as tunable 
physical and chemical properties. As transport containers, the 
particles can be loaded with various components. Fluorescent 
labelling makes it possible to optically monitor delivery 
efficiency [15, 16]. 
In the current study, fluorescence spectroscopy was used to 
assess the allocation of fluorescently labelled polymer 
nanoparticles in the blood circulatory system of healthy rats. 
The aim of the study was to find informative points (areas) on 
the rat skin for transcutaneous fluorescence measurements, and 
to study the dynamics of the fluorescent-labelled (rhodamine 
tetramethylrhodamine (TRITC)) nanocapsules injected into 
the circulatory system. 
2. Materials and methods 
The fluorescence spectroscopy system with a fibre-optical 
probe ‘LAKK-M’ (SPE ‘LAZMA’ Ltd, Russia) was used for 
the in vivo measurements (see figure 1). The system provides 
multiwavelength excitation, registers emission and processes 
the detected fluorescence signal. It includes fluorescence 
excitation in UV (λ  =  365 nm, 1.5 mW), blue (λ  =  450 nm, 
power  =  3.5 mW) and green light (λ  =  532 nm, power  =  4.5 
mW). The above-mentioned fluorescence excitation powers 
are provided at the tip of the fibre probe, which induces an 
excitation light flux in the tissue of no more than 0.16 W m−2 
for 365 nm and 0.37 W m−2 for 450 nm. The spectrophotometer 
was a polychromator with a diffraction grating and a CCD 
(TCD1304AP, Toshiba, Tokyo, Japan) as a detector. 
Polymeric capsules were fabricated using calcium 
carbonate (CaCO3) particles as a sacrificial template. The 
CaCO3 particles were prepared according to the standard 
method described by Parakhonskiy et al [15]. The CaCl2 (0.33 
M) and Na2CO3 (0.33 M) aqueous solutions, dissolved in 20 
ml ethylene glycol, were mixed under vigorous stirring for 3 h, 
leading to the precipitation of CaCO3 particles. Then, the 
CaCO3 particles were washed with pure water to remove the 
unreacted species. Spherical CaCO3 particles with an average 
diameter of 500  ±  100 nm were obtained. The structure of the 
polymeric capsule shells included biodegradable 
polyelectrolyte dextran sulfate (DS, MW  >  70 000) and poly-
L-arginine hydrochloride (PARG, MW  >  70 000). A 
combination of PARG and DS is mostly used for the 
preparation of bio-capsules via the layer-bylayer method [11]. 
The process of layer-by-layer polymer film assembly is based 
on the interaction and self-organization of complementary 
macromolecular pairs with the formation of a water-insoluble 
complex on the template surface. The process begins with the 
adsorption of the polycation (PARG) from the aqueous 
solution onto the negatively charged surface of the template. 
At the next step, the polyanion (DS) is adsorbed onto the 
positively charged surface of the template, and again the sign 
of the surface charge of the template becomes negative. A step-
by-step repetition of the described procedure leads to the 
formation of a water-insoluble polyanion/polycation complex 
on the template surface (see figure 2(a)). Further, the CaCO3 
core is removed by ethylenediaminetetraacetic acid disodium 
salt. The capsules were labelled with fluorescent dye 
rhodamine TRITC (see figure 2(b)). TRITC is a bright red 
fluorescent dye with excitation ideally suited to the 532 nm 
laser line. Using this wavelength, we can observe the whole 
epidermis as well as a papillary layer of the dermis, which 
allows the presence of the nanocapsules in the 
microcirculatory system of the skin to be validated. 
Characterization of the obtained microcapsules was carried out 
using confocal laser scanning microscopy (CLSM) and 
scanning electron microscopy (SEM) (see figure 2). 
 
Figure 1. Exterior view of the experimental setup: (a) the multifunctional laser diagnostic complex LAKK-M control unit with laser and 
optical fibre; (b) the design of the fiber diagnostic probe used in the study ((1) is the collection fiber, (2) is a laser of 532 nm); (c) the 
laboratory rat used in the experiments. 
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Figure 2. Capsule morphology analysis. SEM (a), and the CLSM (b) of the polyelectrolyte nanocomposite capsules. (a) The SEM 
measurements demonstrated the integrity of the nanofunctionalized shells and hollow inner cavity. (b) A CLSM scan at the emission 
bandwidth of the rhodamine TRITC dye. 
 
 
 
 
 
 
Figure 3. The averaged fluorescence spectra distribution of the leg ((a)—control rat group, (c)—capsule rat group) and tail ((b)—
control rat group, (d)—capsule rat group). 
( a ) ( b ) 
( c ) ( d ) 
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Figure 4. The dynamics of the intensity of normalized fluorescence in the control group (a) and in the group that received fluorescent- 
labelled (rhodamine TRITC) nanocapsules (b). 
3. Results and discussion 
Experimental studies were carried out on groups of clinically 
healthy Wistar rats. The animals were held in quaranti ne for 
two weeks in the vivarium of the Centre of Preclinical 
Research, JSC ‘Retinoids’, with temperature, humidity, 
bacterial contamination and day–night cycle conditions 
according to good laboratory practice principles. Every day 
during the quarantine the animals were examined by a 
veterinarian, after that they were randomised into two groups 
according to their weight medians. During the experiment, the 
rats were anaesthetised with Zoletil 100 (Virbac, France) in 
standard doses. The model animals were divided into two 
groups, which received the same food. In the study, twelve 
100–120 g Wistar rats were divided into two groups: one was 
treated with rhodamine-loaded capsules, injected directly into 
the bloodstream (n  =  6), and the second was the control (n  =  
6). Before administration of the drug, background fluorescence 
was measured at a 532 nm excitation wavelength and due to 
the better repeatability, the measurement points on the rats’ 
thighs were selected. The treated group of rats received 
injections of rhodamine capsules into the tail vein. The 
concentration of the resulting rhodamine in the group was 5 
mg kg−1 of the animal weight. The fluorescence spectra were 
recorded from the thighs of anaesthetised rats for 90 min at 10 
min intervals. A preliminary series of measurements of the 
repeatability of the skin fluorescence intensity was conducted 
in the control group. Before each measurement the skin was 
depilated and cleaned with 96% ethanol solution. After the 
experiment, the animals were euthanized in the CO2 chamber. 
The exper imental studies complied with EU Directive 
2010/63/ EU, which defines the human attitude towards 
animals and refers to the principles of the three Rs 
(replacement, reduction and refinement). All studies were 
approved by the Ethical Committee of Orel State University. 
The obtained fluorescence spectra show a statistically 
significant increase in the fluorescence intensity in the group 
of rats that received nanocapsules with rhodamine. In this 
group, a significant increase (from 42  ±  5 to 100  ±  7 a.u., 
two-fold the baseline level) at the wavelength of the peak of 
the rhodamine TRITC fluorescence intensity (about 576 nm) 
was registered (figure 3) 
Imax 
  kf =  (1) 
Ibs +Imax 
where kf is the normalised fluorescence intensity, Imax 
represents the registered fluorescence intensity at 590 nm, and 
Ibs represents the maximum intensity of the backscattered laser 
radiation from the tissue (532 nm). The normalised procedure 
is necessary to compensate the variable absorption in skin and 
get more reliable measurement results (figure 4). 
4. Conclusion 
In this study, we used fluorescence spectroscopy to evaluate 
the penetration efficiency of nanocapsules from the circulatory 
system into adjacent tissues. Since porous containers have the 
potential to accumulate a significant amount of fluorescent 
dye, one of the methods for evaluating the effectiveness of 
transport involves measuring the fluorescence intensity on the 
surface of the body. The obtained fluorescence spectra show a 
statistically significant increase in fluorescence intensity in a 
group of rats that received nanocapsules with rhodamine. In 
this group, a significant increase (two-fold the baseline level) 
at the peak fluorescence intensity of the used dye (λ  =  590 
nm) from 42  ±  5 to 100  ±  7 a.u. was registered. The results 
show that fluorescence spectroscopy can be used to 
transcutaneously measure the concentration dynamics of 
labelled particles in vivo. The approach can increase the 
statistical significance and reliability of preclinical trials and 
reduce the required number of animals providing valuable 
information about pharmacodynamics and the optimal dosage 
of the drug. The results can be used in the field of preclinical 
drug research to control and ensure possible drug-in-place 
delivery as well as in the process of high-throughput screening 
during trials. Future studies will be focused on the 
implementation of targeted delivery—the creation of 
directional transport systems for medicines delivered to a 
particular type of tissue. 
( a ) ( b ) 
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